GCL
MTACU

Glazer Capital LLC’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Glazer Capital LLC’s Portfolio MTACU Stock Details MTACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-51,343
Closed -$516K – 987
2021
Q1 		$516K Buy
51,343
+41,043
+398% +$437K 0.01% 572
2020
Q4 		$108K Buy
+10,300
New +$107K ﹤0.01% 352

Other funds holding MTACU

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HP
Hartree Partners New York $467M AUM 66.71% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
IM
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Glazer Capital LLC's MTACU Position: Q2 2021 in Review

Glazer Capital LLC sold out of MedTech Acquisition Corporation Unit (MTACU) in Q2 2021, closing a stake of 51,343 shares — an estimated $516K sold.

Glazer Capital LLC first reported a position in MTACU in Q4 2020 and held it in 2 quarters. The position peaked at $516K in Q1 2021. 30 funds tracked by Wall St. Rank hold MTACU as of Q2 2021.

  • Glazer Capital LLC reported no remaining MedTech Acquisition Corporation Unit position as of Q2 2021 after selling out during the quarter.
  • Glazer Capital LLC sold 51,343 MedTech Acquisition Corporation Unit shares in Q2 2021, an estimated $516K.
  • Glazer Capital LLC first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 2 quarters.
  • Glazer Capital LLC's MedTech Acquisition Corporation Unit position peaked at $516K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q2 2021.

Based on Glazer Capital LLC's 13F filing for Q2 2021, filed 13 Aug 2021.